120 related articles for article (PubMed ID: 4687877)
1. Serum copper in Hodgkin's disease in children.
Tessmer CF; Hrgovcic M; Wilbur J
Cancer; 1973 Feb; 31(2):303-15. PubMed ID: 4687877
[No Abstract] [Full Text] [Related]
2. Significance of serum copper levels in adult patients with Hodgkin's disease.
Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
[No Abstract] [Full Text] [Related]
3. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
Wilimas J; Thompson E; Smith KL
Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
[TBL] [Abstract][Full Text] [Related]
4. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
Thorling EB; Thorling K
Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
[TBL] [Abstract][Full Text] [Related]
5. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
6. Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease.
Jelliffe AM
Natl Cancer Inst Monogr; 1973 May; 36():325-6. PubMed ID: 4744592
[No Abstract] [Full Text] [Related]
7. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
Asbjörnsen G
Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
[TBL] [Abstract][Full Text] [Related]
8. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
Gupta SK; Shukla VK; Gupta V; Gupta S
J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
[TBL] [Abstract][Full Text] [Related]
9. Prolonged observations on variations in the serum copper in Hodgkin's disease.
Warren RL; Jelliffe AM; Watson JV; Hobbs CB
Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
[No Abstract] [Full Text] [Related]
10. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.
Hrgovcic M; Tessmer CF; Minckler TM; Mosier B; Taylor GH
Cancer; 1968 Apr; 21(4):743-55. PubMed ID: 4868473
[No Abstract] [Full Text] [Related]
11. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
[No Abstract] [Full Text] [Related]
12. Interpreting serum copper levels in Hodgkin's disease.
Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
[No Abstract] [Full Text] [Related]
13. [Diagnostic value of copper, haptoglobin and alpha-2-globulin in the serum of patients with Hodgkin's disease].
Cepelja Z; Grgić Z; Markinković M; Ivanov D
Lijec Vjesn; 1975 May; 97(5):289-93. PubMed ID: 54857
[No Abstract] [Full Text] [Related]
14. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
[No Abstract] [Full Text] [Related]
15. [Diagnostics of relapse in hodgkin's disease (author's transl)].
Dietzel F; Grebe SF; Ristig W; Schmidt HG; Steckenmesser R
Med Klin; 1974 Feb; 69(7):289-92. PubMed ID: 4363084
[No Abstract] [Full Text] [Related]
16. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
Kuleva SA
Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
[TBL] [Abstract][Full Text] [Related]
17. Classification and prognostic value of serum copper/zinc ratio in Hodgkin's disease.
Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Suling H
Biol Trace Elem Res; 2001 Nov; 83(2):133-8. PubMed ID: 11762530
[TBL] [Abstract][Full Text] [Related]
18. Value of laboratory indicators in Hodgkin's disease: preliminary results.
Ray GR; Wolf PH; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
[No Abstract] [Full Text] [Related]
19. [When to terminate the treatment of children with Hodgkin's disease, lymphoblastic leukemia and non-Hodgkin's lymphoma. Analysis of 80 cases].
Armata J
Pediatr Pol; 1979 Aug; 54(8):877-85. PubMed ID: 291888
[No Abstract] [Full Text] [Related]
20. Clinical significance of the blood copper in Hodgkin's disease.
PAGLIARDI E; GIANGRANDI E
Acta Haematol; 1960 Oct; 24():201-12. PubMed ID: 13732060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
